China Clinical Trials: Built For Global Impact
Your Strategic Hub for Faster, Smarter Global Development
Bringing together senior clinical leaders, biotech executives and clinical partners, this half-day forum explores how trials are being designed, executed and scaled in China today, from protocol strategy and delivery, to recruitment, data quality and AI-enabled operations. As China plays an increasingly central role in global development programmes, the forum provides a practical, experience-led perspective on how clinical delivery in China supports both regulatory success and global partnering strategies.
China-To-Global Market Access: Your Strategic Roadmap
China is a strategic powerhouse for global drug development, delivering complex trials, AI-enabled operations and data quality that supports worldwide registrations. Mastering these advanced operational capabilities as the government drives further alignment with wider global standards creates opportunities for significant competitive advantage. Join us ahead of ChinaBio™ Partnering Forum to gain strategic insights, forge partnerships and accelerate your global pipeline.
Master strategic trial design: From regulatory approval to global scalability
Discover how to design clinical protocols that meet NMPA requirements. And, understand how regulatory evolution and protocol decisions interconnect to affect feasibility, timelines and your global pathway success.
Execute complex programs at scale: Patient engagement and late-stage excellence
Unlock practical approaches to achieve consistent recruitment and retention across sites and regions, working with China's diverse patient communities.
Navigate critical partnership decisions: CRO selection and data excellence
Master the strategic choices around Chinese vs global CROs while establishing operational best practices that deliver global-ready data. Explore governance frameworks that ensure quality, speed, and regulatory confidence while building inspection readiness from day one.
Harness technology for competitive advantage: AI-Powered clinical operations
Explore cutting-edge AI applications in data analysis, monitoring, and trial operations for innovative approaches to reduce timelines and improve probability of success.
Define the future standard: China-to-global clinical excellence
Explore how China's evolving clinical trial landscape creates opportunities for domestic innovation and a strong foundation for global development success. Understand the capabilities that will define excellence by 2027 and position your programs to thrive in China's growing market and beyond.
At ChinaBio™ Partnering Forum
Clinical Trials at ChinaBio bridges the gap between clinical execution and business strategy in China's rapidly expanding life sciences market.
This exciting new one-day event takes place before the main ChinaBio™ Partnering Forum begins, delivering the ultimate dual advantage: gain strategic insights to master complex clinical pathways and secure valuable new partnerships to accelerate your pipeline – all in one place.
Who should attend?
Whether you're a China based pharma/biotech company or one evaluating opportunities in China, a CRO staying ahead of the latest clinical research strategies, or a service provider supporting clinical programs, you'll gain strategy-shaping insights from peers who are actively delivering trials within APAC and around the world.
This event is particularly valuable if you're a senior leader, director, or manager responsible for:
• Making strategic decisions about where and how to run trials
• Designing protocols that work within China and across markets
• Ensuring regulatory compliance and data quality
• Managing clinical operations and timelines
• Selecting and managing CROs and vendors
• Evaluating new technologies and AI solutions
• Overseeing procurement and supply chain
• Building capabilities in China or APAC
